International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8360610
Original Article
Clinico-Microbiological Profile of Organisms Isolated from Diabetic Foot Ulcer at Tertiary Care Hospital, Gujarat
 ,
 ,
 ,
 ,
Published
Sept. 18, 2023
Abstract

Introduction: The individuals with diabetes have at least a 10-fold greater risk for soft tissue and bone infections of the foot than individuals without diabetes. The Indian diabetic population is expected to increase up to 57 million by the year 2025.

Aims and Objectives: To evaluate the bacteriological profile and antibiogram of diabetic foot ulcer.

Material and Methods: 150 Samples of diabetic foot ulcers were collected over a period of six months by using sterile swabs and they were processed as per the standard protocol. Pathogenic organisms were isolated, identified by biochemical tests. Antibiotic susceptibility testing was done by Kirby -Bauer disk diffusion method on Mueller Hinton Agar and results were interpreted as per Clinical and Laboratory Standards Institute guidelines.

Results: Bacterial etiology could be identified among 74 cases out of 150 (49.3%), among which Pseudomonas aeruginosa was the commonest (in 25 cases), followed by Klebsiella spp. (in 20 cases), Escherichia coli (in 13 cases), Proteus mirabilis (in 12 cases), Staphylococcus aureus (in 3 cases) and Enterococcus in 1 case.

Conclusion: Gram negative bacilli were more prevalent 70 out of 74 cases (94.5%) than gram positive cocci, 4 out of 74 cases (5.5%). In our study the commonest isolate was Pseudomonas aeruginosa (33.7%), followed by Klebsiella spp. (27.02%) and Escherichia coli (17.56%). Meropenem and Piperacillin/tazobactam are drug of choice in such cases.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
683 Views
52 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved